Advanced Cancer Research

1992-1998-Institute of Critical Care Medicine - Faculty of Medicine, Tbilisi Medical State University •2010 Gr. Robakidze Georgian - American University - PhD, Tbilisi. • 2012 PhD student of the Natural Sciences of Tbilisi State University: Scientific topic: The modern method of treatment of uterine tumors by biomposotic, low-pulmonary drug; Tbilisi. • 1998-2002 National Center for Disease Control - Scientific Worker; Tbilisi. • 2005-2008 Imereti Regional Clinical Hospital-Junior Doctor; Kutaisi. • 2008-2010 Imereti Regional Clinical Hospital-Onco-Hematologist; Kutaisi. • 2007-2010 Tbilisi A Canine Center for Cancer Center - Chemotherapy Junior Doctor; Tbilisi. • 2010-2013 LTD "Sarapi Sarovi Clinic" - Clinical Director, Oncologist, Hematologist. • 2013-2014 Ltd. "Life" - clinical director, oncologist, hematologist. • 2011-2012 Founder of Georgia - Swiss Medical Training Center "MMC"; From 2017 to present "Saroveli" - clinical director, oncologist, hematologist.

Oncologist, Haemotologist

Khalid Matin, M.D., F.A.C.P., has been appointed as a medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective July 15, 2013. Most recently, Matin was director of community oncology and associate professor of oncology at Roswell Park Cancer Institute in Buffalo, New York. He was also an attending physician at Roswell’s satellite facility in Amherst, NY. Prior to his roles at Roswell, Matin was a medical oncologist at the Cancer Center of Montgomery, Alabama, which is part of the Southeast Cancer Network; a clinical assistant professor at the University of Alabama in Birmingham and University of Pittsburgh Cancer Institute in Pennsylvania; and attending physician in hematology-oncology at the Veterans Affairs Medical Center in Pittsburgh. A board-certified medical oncologist and clinical researcher, Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers, and he has served as the principal investigator and co-investigator on various colorectal and lung cancer trials.

Matin is an expert in the study and treatment of gastrointestinal (GI) cancers. He has developed several clinical trials for GI cancers and lung cancer.

Dr Adhip P.N. Majumdar received his MS and PhD degrees from the University of London, England, and D.Sc (Doctor of Science) degree in Gastroenterology from the University of Aarhus, Denmark. Dr. Majumdar has been a Professor at Wayne State University since 1992 and holds the post of Senior Research Career Scientist at the Detroit VA Medical Center. He has published over 200 original scientific articles and a multitude of book chapters/review articles. Dr.Majumdar's lab is particularly interested in elucidating the patho-physiology of age-related changes in the GI mucosa specifically those that lead to malignancy. To this end, Dr Majumdar has been investigating the role of pluripotent, self-renewing CSCs in the development and progression of GI malignancies. Dr Majumdar has been funded by the VA and NIH.

Role of pluripotent, self-renewing CSCs in the development and progression of GI malignancies.

Professor Ioannis S. Patrikios received his BSc degree in Pre-Medical studies/Biochemistry from the City College of the City University of NY. He completed his PhD studies in 1994, specialized on Immunology and Lipids/Lipidomics and post-doctoral studies specialization in Medical Biochemistry at the City College of NY, next to the world-known Professor CS Russell. Professor Patrikios went through several different fellowships including research specializations /collaborations with different high reputation institutions including, Mount Sinai NY and was awarded advanced Immunology specialization courses at Scuola Superiore d'Immunologia Ruggero Ceppellini, Italy. He served and continues to serve as a Research Scientific Consultant for Industry and higher education. His broad research interests include studies of new therapeutic approaches of chronic diseases by the use of Systems Medicine, through Systems Biology and Nutritional Systems Biology; Lipid Hemagglutinins, Lectins, Immunology and the use of novel interventions against Metastatic Tumor Cells. As from 2004, Professor Patrikios got involved in the research of innovative, pioneer, holistic therapeutic approaches for chronic multifactorial Neurodegenerative diseases, specifically of Multiple Sclerosis. He is affiliated as a Graduate Studies Mentor with the Institute of Brain Chemistry of London. During the last decade he has obtained many competitive research grants, participated in several different collaborative European scientific research-projects and he organized several large European Consortium Platforms for research and Clinical Trials. His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest; and have been discussed by several different National Food and Drug Administrations, including UK, and through articles in high impact Magazines such as the New Scientist. He has lately been honored with the tittle of a fellow and member of the advisory board of the Forensic Pathology Academy of London. He has been appointed as a reviewer and editor of several international scientific journals in the field of Medicine, Med-Biochemistry, Pharmaceuticals-Therapeutics and Neurology and as a reviewer for research grants. He is the solid author of University Books in Biochemistry and Medical Biochemistry and he has authored numerous peer-reviewed, limited co-authored original publications, in high impact factor scientific journals. Professor Patrikios is a member of several International associations and bodies including Sigma Xi. He is the chief scientific investigator of the team which lately invented and patented the nutraceutical formula PLP10 as a new therapeutic intervention for multiple sclerosis. He is the co-founder and Director of PALUPA Medical Ltd (a research and innovation company), that performed and successfully completed the phase II clinical trial for PLP10. Now he is the scientific coordinator of the “MINERAL” phase III multicenter clinical trial for PLP10. At present he is a Professor, Faculty of Medicine and the Chairman of the School of Medicine of the European University of Cyprus and affiliated as a research collaborator at the Cyprus Institute of Neurology and Genetics.

His 2002 research findings on the effect of frying oils as human hemagglutinins got an international interest, and have been discussed by several different National Food and Drug Administrations

Doctor of Medicine (M.D.) by the University of the Republic of Uruguay. Traineeship Program Advanced in Radiation Oncologist - (Resident Medical Practitioner), at the University Hospital Donostia of San Sebastian. (Spain). Fellowship / Training Program Advanced Clinical Practitioner - Proton and Carbon Ion Therapy (Hadron therapy) at Fondazione CNAO (Pavia - Italy). International Master for Advanced Technological in Radiation Oncology, at the University of Murcia and the GenesisCare Foundation. Consultant Radiation Oncologist in public and private hospitals (QuironSalud - GenesisCare) of Spain. Member of the Particle Therapy Co-Operative Group (PTCOG), and Co-Founder / Chairman at the Spanish Proton Therapy Group (SPTG - AEPROT).

cancer, proton therapy, carbon ion therapy, particle therapy.

He is the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program.

Neuroscience, Regenerative Medicine, Continued Medical Education, Cancer, Oncology, Information & Communications Technology, Biotechnology, Social Development, Energy Technologies.